Bayer: A history
By GMWatch,
GMWatch
| 04. 19. 2022
How a chemical and pharmaceutical giant with an appalling record of corporate crimes became a key player in the development, commercialization and sale of GM crops
Bayer AG is a chemical and pharmaceutical giant founded in Barmen, Germany in 1863 by Friedrich Bayer and his partner, Johann Friedrich Weskott. Today it has its headquarters in Leverkusen, North Rhine-Westphalia, Germany.
The merger between Bayer and Monsanto in June of 2018 led many commentators to say the German firm had sullied its reputation by taking over a company consistently shown in polls to be among the most hated in America. But Bayer's own corporate record also bears little scrutiny.
A look at the company's history may, in fact, help to explain how Bayer thought it could take over a firm up to its neck in controversies and court cases and just rebrand Monsanto's products as its own and rake in the profits. After all, as we shall see, for more than a century Bayer has been walking away from corporate crimes from which it has successfully profited.
The product that Bayer is perhaps most famous for is aspirin, which it trademarked in 1899. Bayer's official history has credited Felix Hoffmann with its invention in 1897. But according to Arthur Eichengrün, another chemist employed by Bayer at the time, he...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...